Acurx Pharmaceuticals LLC (ACXP) financials · $11.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Acurx Pharmaceuticals LLC (ACXP) $11.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$8.09M | -$14.1M |
| Net Income | -$7.97M | -$14.1M |
| EPS (Diluted) | -$5.32 | -$0.87 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $7.69M | $3.86M |
| Current Assets | N/A | $3.86M |
| Cash & Equivalents | $7.56M | $3.71M |
| Total Liabilities | $2.42M | $3.24M |
| Current Liabilities | $2.42M | $3.24M |
| Shareholders' Equity | $5.27M | $615.1K |
| Retained Earnings | -$75.3M | -$67.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$6.79M | -$10.4M |
| Financing Cash Flow | $10.6M | $6.62M |
| Net Change in Cash | $3.85M | -$3.77M |
FAQ
What is ACXP P/E and revenue?
Acurx Pharmaceuticals LLC (ACXP) $11.3M cap.
What is ACXP revenue?
ACXP income-statement cache has no revenue figure yet.
Is ACXP profitable?
Acurx Pharmaceuticals LLC last cached net income is -$7.97M (FY2025).
What are ACXP total assets?
Acurx Pharmaceuticals LLC last cached total assets are $7.69M (FY2025).
What is ACXP free cash flow?
No cached cash-flow row for ACXP yet.
Not investment advice. Cached statements, not a live tape.